• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Dihydroergotamine Mesylate Injection

 Status: Currently in Shortage

 » Date first posted: 08/06/2014
 » Therapeutic Categories: Neurology

Paddock Laboratories, LLC (Reverified 01/07/2015)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/mL ampoule, 10s (NDC 0574-0850-10)